GlassScriptPhysician profile
William A Montagne
NPI 1952938854
$2,337.32
in general payments reported to CMS, 2019-2025
11 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $601 · 2022: $355 · 2023: $596 · 2024: $183 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $740.75 | 2023-2025 | Pteye Parathyroid Detection System, Propel, Sinuva |
| Stryker Corporation | $662.47 | 2021-2024 | Na, Vsp System, Vsp Cranial, Core |
| Acera Surgical, INC. | $345.86 | 2021-2023 | Restrata Wound Matrix |
| Axogen | $203.08 | 2022-2025 | |
| Kls-Martin L.P. | $99.51 | 2023 | |
| Allergan, INC. | $85.59 | 2022 | |
| Glaxosmithkline, LLC. | $77.32 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $46.05 | 2021 | |
| Merck Sharp & Dohme LLC | $32.34 | 2025 | Keytruda |
| Olympus America INC. | $29.43 | 2024 | Rhino-Laryngo Videoscope |
| Optinose US, INC. | $14.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Montagne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.